32.06
Ishares Neuroscience And Healthcare Etf stock is traded at $32.06, with a volume of 329.
It is down -0.97% in the last 24 hours and down -2.76% over the past month.
See More
Previous Close:
$32.38
Open:
$32.0594
24h Volume:
329
Relative Volume:
0.27
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.80%
1M Performance:
-2.76%
6M Performance:
+44.75%
1Y Performance:
+25.27%
Ishares Neuroscience And Healthcare Etf Stock (IBRN) Company Profile
Name
Ishares Neuroscience And Healthcare Etf
Sector
Industry
Phone
-
Address
-
Compare IBRN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IBRN
Ishares Neuroscience And Healthcare Etf
|
32.06 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
340.14 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
689.51 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
692.55 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
269.23 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
620.47 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Neuroscience And Healthcare Etf Stock (IBRN) Latest News
Trading Systems Reacting to (IBRN) Volatility - Stock Traders Daily
SPDR Portfolio TIPS ETF (NYSEARCA:SPIP) Short Interest Up 196.5% in December - Defense World
Avoiding Lag: Real-Time Signals in (IBRN) Movement - Stock Traders Daily
iShares neuroscience and healthcare ETF declares annual distribution of $0.3198 - MSN
Evercore ISI maintains MedinCell (MDCLF) outperform recommendation - MSN
(IBRN) Risk Channels and Responsive Allocation - Stock Traders Daily
Brighthouse Financial (NASDAQ:BHFAN) Trading Down 2.2% – Should You Sell? - Defense World
(IBRN) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - The AI Journal
Liquidity Mapping Around (IBRN) Price Events - news.stocktradersdaily.com
IBRN Stock Institutional Owners - Quiver Quantitative
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month - sharewise.com
Why (IBRN) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Do Wall Street Analysts Like AbbVie Stock? - FinancialContent
Short Interest in Plumas Bancorp (NASDAQ:PLBC) Expands By 64.6% - Defense World
Star Equity (NASDAQ:STRRP) Trading Down 3.9% – What’s Next? - Defense World
JTC (OTCMKTS:JTCPF) Stock Price Up 4% – Should You Buy? - Defense World
EnSilica (LON:ENSI) Shares Up 2.8% – Here’s Why - Defense World
Oncology Institute (NASDAQ:TOIIW) Trading Up 57.7% – Time to Buy? - Defense World
United Maritime (NASDAQ:USEA) Stock Price Down 0.3% – Here’s Why - Defense World
Rural Funds Group (OTC:RFNDF) Trading Up 4% – Should You Buy? - Defense World
Itafos (OTCMKTS:MBCF) Trading Down 0.7% – What’s Next? - Defense World
Understanding Momentum Shifts in (IBRN) - news.stocktradersdaily.com
Can You Invest in Neuralink? - Investing News Network
HeartSciences (NASDAQ:HSCS) Trading Up 10.9% – Still a Buy? - Defense World
VanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 37.5% in July - Defense World
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Alto Neuroscience (ANRO) Projected to Post Quarterly Earnings on Tuesday - Defense World
Hypercharge Networks (OTCMKTS:HCNWF) Trading 29.7% Higher – Should You Buy? - Defense World
Diversified Healthcare Trust (NASDAQ:DHCNL) Stock Price Down 0.3% – Time to Sell? - Defense World
Brighthouse Financial (NASDAQ:BHFAO) Shares Up 6.2% – Here’s Why - Defense World
Stifel Financial (NYSE:SF) Lowered to Sell Rating by Wall Street Zen - Defense World
Long Term Trading Analysis for (IBRN) - news.stocktradersdaily.com
(IBRN) Technical Data - news.stocktradersdaily.com
Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland - 富途牛牛
VistaShares Animal Spirits Daily 2X Strategy ETF Holdings List (NYSEARCA:WILD) - MarketBeat
iShares Neuroscience and Healthcare ETF (IBRN) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
Healthcare Sector Slides As Hinge Health Shines Post-IPO - Finimize
Do Wall Street Analysts Like Biogen Stock? - Barchart.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
497: Periodic update to fund prospectus - 富途牛牛
497J: Others - 富途牛牛
Biogen’s Stock Outlook: Analysts’ Views on Its Future Performance - Kalkine Media
Top 5 Life Science ETFs - Investing News Network
Healthcare Innovation Portfolio: Balancing Exposure and Capturing Upsides - Syfe
(IBRN) Long Term Investment Analysis - news.stocktradersdaily.com
N-PX: Others - 富途牛牛
What Are Wall Street Analysts' Target Price For Lennar Stock? - Barchart.com
Is Wall Street Bullish Or Bearish On Biogen Stock? - Barchart.com
Where to Invest in Health Trends - Bloomberg.com
Ishares Neuroscience And Healthcare Etf Stock (IBRN) Financials Data
There is no financial data for Ishares Neuroscience And Healthcare Etf (IBRN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):